{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:40:43Z","timestamp":1790660443318,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1124\/jpet.106.119156","type":"journal-article","created":{"date-parts":[[2007,4,10]],"date-time":"2007-04-10T00:49:33Z","timestamp":1176166173000},"page":"369-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats"],"prefix":"10.1016","volume":"322","author":[{"given":"William A.","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Ogletree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Steinbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pancras C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Rehfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.119156_bib1","doi-asserted-by":"crossref","unstructured":"Aleil B, Ravanat C, Cazenave JP, Rochoux G, Heitz A, and Gachet C (2005) Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3: 85-92.","DOI":"10.1111\/j.1538-7836.2004.01063.x"},{"key":"10.1124\/jpet.106.119156_bib2","doi-asserted-by":"crossref","unstructured":"Baurand A, Eckly A, Bari N, L\u00e9on C, Hechler B, Cazenave J-P, and Gache C (2000) Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84: 484-491.","DOI":"10.1055\/s-0037-1614049"},{"key":"10.1124\/jpet.106.119156_bib3","doi-asserted-by":"crossref","unstructured":"CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 348: 1329-1339.","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"10.1124\/jpet.106.119156_bib4","doi-asserted-by":"crossref","unstructured":"Cattaneo M (2006) ADP receptors: inhibitory strategies for antiplatelet therapy. Drug News Perspect 19: 253-259.","DOI":"10.1358\/dnp.2006.19.5.985936"},{"key":"10.1124\/jpet.106.119156_bib5","doi-asserted-by":"crossref","unstructured":"Das J, Kimball S, Hall SE, Han W, Iwanowicz E, Lin J, Moquin RV, Reid JA, Sack JS, Malley MF, et al. (2002) Molecular design and structure-activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664. Bioorg Med Chem Lett 12: 45-49.","DOI":"10.1016\/S0960-894X(01)00667-9"},{"key":"10.1124\/jpet.106.119156_bib6","doi-asserted-by":"crossref","unstructured":"Daykin HJ, Sturgeon SA, Jones C, and Wright CE (2006) Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat. Thromb Res 118: 755-762.","DOI":"10.1016\/j.thromres.2005.11.015"},{"key":"10.1124\/jpet.106.119156_bib7","doi-asserted-by":"crossref","unstructured":"Geiger J, Brich J, Honig-Liedl P, Eigenthaler M, Schanzenbacher P, Herbert JM, and Walter U (1999) Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 19: 2007-2011.","DOI":"10.1161\/01.ATV.19.8.2007"},{"key":"10.1124\/jpet.106.119156_bib8","doi-asserted-by":"crossref","unstructured":"Grossmann R, Sokolova O, Schnurr A, Bonz A, Porsche C, Obergfell A, Lengenfelder B, Walter U, and Eigenthaler M (2004) Variable extent of clopidogrel responsiveness in patients after coronary stenting. Thromb Haemost 92: 1201-1206.","DOI":"10.1160\/TH04-01-0049"},{"key":"10.1124\/jpet.106.119156_bib9","doi-asserted-by":"crossref","unstructured":"Herbert JM, Bernat A, and Maffrand JP (1993) Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thromb Res 71: 433-441.","DOI":"10.1016\/0049-3848(93)90117-7"},{"key":"10.1124\/jpet.106.119156_bib10","doi-asserted-by":"crossref","unstructured":"Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409: 202-207.","DOI":"10.1038\/35051599"},{"key":"10.1124\/jpet.106.119156_bib11","doi-asserted-by":"crossref","unstructured":"Labarthe B, Th\u00e9roux P, Mand A, and Ghitescu M (2005) Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 46: 638-645.","DOI":"10.1016\/j.jacc.2005.02.092"},{"key":"10.1124\/jpet.106.119156_bib12","doi-asserted-by":"crossref","unstructured":"Leadley RJ Jr, Chi L, Rebello SS, and Gagnon A (2000) Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. J Pharmacol Toxicol Methods 43: 101-116.","DOI":"10.1016\/S1056-8719(00)00095-2"},{"key":"10.1124\/jpet.106.119156_bib13","doi-asserted-by":"crossref","unstructured":"Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, and Serebruany V (2007) Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: The VERIfy Thrombosis risk AS-sessment (VERITAS) study. Thromb Res 119: 277-284.","DOI":"10.1016\/j.thromres.2006.01.019"},{"key":"10.1124\/jpet.106.119156_bib14","doi-asserted-by":"crossref","unstructured":"Nguyen TA, Diodati JG, and Pharand C (2005) Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 45: 1157-1164.","DOI":"10.1016\/j.jacc.2005.01.034"},{"key":"10.1124\/jpet.106.119156_bib15","doi-asserted-by":"crossref","unstructured":"Phillips DR, Conley PB, Sinha U, and Andre P (2005) Therapeutic approaches in arterial thrombosis. J Thromb Haemost 3: 1577-1589.","DOI":"10.1111\/j.1538-7836.2005.01418.x"},{"key":"10.1124\/jpet.106.119156_bib16","doi-asserted-by":"crossref","unstructured":"Savi P and Herbert JM (2005) Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 31: 174-183.","DOI":"10.1055\/s-2005-869523"},{"key":"10.1124\/jpet.106.119156_bib17","doi-asserted-by":"crossref","unstructured":"Schumacher WA, Heran CL, Youssef S, Megill JR, Michel I, and Durham SK (1993) Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis. Haemostasis 23: 219-228.","DOI":"10.1159\/000216878"},{"key":"10.1124\/jpet.106.119156_bib18","doi-asserted-by":"crossref","unstructured":"Schumacher WA, Steinbacher TE, Megill JR, and Durham SK (1996) A ferret model of electrical-induction of arterial thrombosis that is sensitive to aspirin. J Pharmacol Toxicol Methods 35: 3-10.","DOI":"10.1016\/1056-8719(95)00099-2"},{"key":"10.1124\/jpet.106.119156_bib19","unstructured":"Thebault JJ, Kieffer G, Lowe GD, Nimmo WS, and Cariou R (1999) Repeated dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost 25 (Suppl 2): 9-14."},{"key":"10.1124\/jpet.106.119156_bib20","doi-asserted-by":"crossref","unstructured":"van Gestel MA, Heemskerk JW, Slaaf DW, Heijnen VV, Reneman RS, and Oude Egbrink MG (2003) In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arterioscler Thromb Vasc Biol 23: 518-523.","DOI":"10.1161\/01.ATV.0000057809.32354.22"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524339552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524339552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.119156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:19:32Z","timestamp":1740003572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524339552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0022356524339552"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.119156","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker Optimization to Track the Antithrombotic and Hemostatic Effects of Clopidogrel in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.119156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}